DigestRedComo funciona
Red
/
Empresas
Co
No verificado

Cognito Therapeutics

Sobre qué escribimos

CienciaIndustriaIr de comprasMedicina - VariosSalud

23 Comunicados de prensa

Ver todos los comunicados de prensa
08/04/2026
Multimedia
Voluntariado/Solidaridad/ONGs
Software
Ciencia
Hardware
Farmacéutica
Tecnología de la información
Ir de compras
Técnica
Material médico sanitario
Medicina - Varios
Biotecnología
Tercera edad
Salud
Cognito Therapeutics Partners with Initiative to Change the “D-Word,” Commits to Eliminating Use of “Dementia” Across All Communications
Fuente
Cognito Therapeutics
Editor
Business Wire
1.00
0
25/03/2026
Cognito Therapeutics and Ochsner Health Launch Brain Health Collaboratory to Advance New Care Models for Alzheimer’s Disease
Fuente
Cognito Therapeutics
Editor
Business Wire
1.00
0
17/03/2026
Cognito Therapeutics Presents New Data on Spectris™ in Alzheimer’s Disease at AD/PD™ 2026
Fuente
Cognito Therapeutics
Editor
Business Wire
1.00
0
11/03/2026
Cognito Therapeutics Appoints Thomas Fagan as Executive Vice President, Alzheimer’s Portfolio
Fuente
Cognito Therapeutics
Editor
Business Wire
1.00
0
05/03/2026
Cognito Therapeutics Announces Oversubscribed $105 Million Series C Financing to Advance Spectris™ in Alzheimer’s Disease
Fuente
Cognito Therapeutics
Editor
Business Wire
1.00
0
03/12/2025
Cognito Therapeutics Announces Presentation of New CSF Proteomic and EEG Biomarker Data for Spectris™ in Alzheimer’s Disease at CTAD 2025
Fuente
Cognito Therapeutics
Editor
Business Wire
1.00
0
18/11/2025
Software
Ciencia
Hardware
Ir de compras
Técnica
Material médico sanitario
Medicina - Varios
Biotecnología
Tercera edad
Salud
Eventos
Industria
Cognito Therapeutics to Present New Biomarker Data for Spectris™ in Alzheimer’s Disease at CTAD 2025
Fuente
Cognito Therapeutics
Editor
Business Wire
1.00
0
13/11/2025
WVU Rockefeller Neuroscience Institute and Cognito Therapeutics Launch Brain Health Collaboratory to Accelerate Neurotherapies with AI-powered Research
Fuente
Cognito Therapeutics
Editor
Business Wire
1.00
0
28/07/2025
Cognito Therapeutics Presents Clinical Trial Data Highlighting Neuroprotective Potential of Spectris™ in Alzheimer’s Disease at AAIC 2025
Fuente
Cognito Therapeutics
Editor
Business Wire
1.00
0
17/07/2025
Eventos
Industria
Tercera edad
Biotecnología
Salud
Material médico sanitario
Ir de compras
Medicina - Varios
Cognito Therapeutics to Present Five Abstracts at AAIC 2025 Highlighting Spectris™ Treatment in Alzheimer’s Disease
Fuente
Cognito Therapeutics
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0